Metabolic syndrome: prevalence, associated factors, and C-reactive protein. The MADRIC (MADrid RIesgo Cardiovascular) Study

Metabolism: Clinical and Experimental

Volumn 57, Issue 9, 2008, Pages 1232-1240

  Martínez, Maria A ^a   Puig, Juan G ^b   Mora, Marta ^b   Aragón, Rosa ^c   O'Dogherty, Pascual ^d   Antón, José L ^c   Sánchez Villares, Teresa ^c   Rubio, José M ^b   Rosado, Javier ^b   Torres, Rosa ^b   Marcos, Joaquín ^d   Pallardo, Luis F ^b   Banegas, José R ^e  

^a HOSPITAL UNIVERSITARIO INFANTA SOFÍA   (Spain)

^b HOSPITAL UNIVERSITARIO LA PAZ   (Spain)

^c El Molar Primary Care Centre ^*

^d La Paz Teaching Hospital   (Nigeria)

^e UNIVERSIDAD AUTÓNOMA DE MADRID   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

C REACTIVE PROTEIN; GLUCOSE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; TRIACYLGLYCEROL;

ADULT; AGED; ARTICLE; DEMOGRAPHY; EDUCATIONAL STATUS; FEMALE; HUMAN; IMMOBILIZATION; LIFESTYLE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; METABOLIC SYNDROME X; PHYSICAL EXAMINATION; PREVALENCE; PRIORITY JOURNAL; WAIST CIRCUMFERENCE;

ADULT; AGE DISTRIBUTION; AGED; ANTHROPOMETRY; C-REACTIVE PROTEIN; CROSS-SECTIONAL STUDIES; DEMOGRAPHY; EDUCATIONAL STATUS; FEMALE; HUMANS; LIFE STYLE; LOGISTIC MODELS; MALE; METABOLIC SYNDROME X; MIDDLE AGED; MOTOR ACTIVITY; PREDICTIVE VALUE OF TESTS; PREVALENCE; RISK FACTORS; SEX DISTRIBUTION; SPAIN;

EID: 49149126215     PISSN: 00260495     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.metabol.2008.04.017     Document Type: Article

References (33)

1. Sarafidis P.A., and Nilsson P.M. The metabolic syndrome: a glance at its history. J Hypertens 24 (2006) 621-626
2. Das U.N. Metabolic syndrome X: an inflammatory condition?. Curr Hypertens Rep 6 (2004) 66-73
3. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults. Executive summary of the third report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III). JAMA 285 (2001) 2486-2497
4. Grundy S.M., Cleeman J.I., Daniels S.R., et al. Diagnosis and management of the metabolic syndrome: an American Heart Association/National Heart, Lung, and Blood Institute Scientific Statement (published corrections appear in Circulation 2005;112: e298). Circulation 112 (2005) 2735-2752
5. International Diabetes Federation. New diagnostic criteria for metabolic syndrome. Access in:. http://www.idf.org/webdata/docs/MetS_def_update2006.pdf
6. Ford E.S., Giles W.H., and Mokdad A.H. Increasing prevalence of the metabolic syndrome among U.S. adults. Diabetes Care 27 (2004) 2444-2449
7. Balkau B., Vernay M., Mhamdi L., et al. The incidence and persistence of the NCEP (National Cholesterol Education Program) metabolic syndrome. The French DESIR study. Diabetes Metab 29 (2003) 526-532
8. Ozsahin A.K., Gokcel A., Sezgin N., et al. Prevalence of the metabolic syndrome in a Turkish adult population. Diabetes Nutr Metab 17 (2004) 230-234
9. Lorenzo C., Serrano-Ríos M., Martínez-Larrad M.T., et al. Geographic variations of the International Diabetes Federation and the National Cholesterol Education Program-Adult Treatment Panel III definitions of the metabolic syndrome in nondiabetic subjects. Diabetes Care 29 (2006) 685-691
10. Álvarez E., Ribas L., and Serra L. Prevalence of the metabolic syndrome in the population of Canary Islands, Spain. Med Clin (Barc) 120 (2003) 172-174 [In Spanish]
11. Martínez-Larrad M.T., Fernández-Pérez C., González-Sánchez J.L., Serrano-Ríos M., et al. Prevalence of metabolic syndrome (ATP III criteria). Population-based study in rural and urban areas of the province of Segovia. Med Clin (Barc) 125 (2005) 481-486 [in Spanish]
12. Müller-Nordhornn J., Binting S., Roll S., and Willich S.N. An update on regional variation in cardiovascular mortality within Europe. Eur Heart J (2008) [Electronic publication ahead of print]
13. Banegas J.R., and Rodríguez-Artalejo F. Cardiovascular risk in the Spanish population. Geographic heterogeneity?. Rev Clin Esp 204 (2004) 611-613 [in Spanish]
14. Ford E.S. Prevalence of the metabolic syndrome defined by the International Diabetes Federation among adults in the U.S. Diabetes Care 28 (2005) 2745-2749
15. Moebus S., Hanisch J.U., Aidelsburger P., et al. Impact of 4 different definitions used for the assessment of the prevalence of the metabolic syndrome in primary healthcare: the German Metabolic and Cardiovascular Risk Project (GEMCAS). Cardiovasc Diabetol 6 (2007) 22-32
16. Choi K.M., Kim S.M., Kim Y.E., et al. Prevalence and cardiovascular disease risk of the metabolic syndrome using National Cholesterol Education Program and International Diabetes Federation definitions in the Korean population. Metabolism 56 (2007) 552-558
17. Bonora E., Kiechl S., Willeit J., et al. Metabolic syndrome: epidemiology and more extensive phenotypic description. Cross-sectional data from the Bruneck Study. Int J Obes Relat Metab Disord 27 (2003) 1283-1289
18. Athyros V.G., Bouloukos V.I., Pehlivanidis A.N., et al. The prevalence of the metabolic syndrome in Greece: the MetS-Greece Multicentre Study. Diabetes Obes Metab 7 (2006) 397-406
19. Banegas J.R., Villar F., Graciani A., and Rodríguez-Artalejo F. Epidemiology of cardiovascular diseases in Spain. Rev Esp Cardiol (2006) 3G-12G [in Spanish]
20. Alimentación y nutrición en la Comunidad de Madrid. Observatorio de Alimentación de la Comunidad de Madrid, 2006. Documento Técnico n° 108. Accessed 28 February 2008. Available from:. http://www.publicaciones-isp.org/productos/d108.pdf [in Spanish]
21. Schröder H., Marrugat J., Vila J., Covas M.I., and Elosua R. Adherence to the traditional Mediterranean diet is inversely associated with body mass index and obesity in a Spanish population. J Nutr 134 (2004) 3355-3361
22. Panagiotakos D.B., Pitsavos C., Chrysohoou C., et al. Impact of lifestyle habits on the prevalence of the metabolic syndrome among Greek adults from the ATTICA study. Am Heart J 147 (2004) 106-112
23. European mortality data base (MDB). World Health Organization Regional Office for Europe. Accessed 25 March 2008. Available from:. http://data.euro.who.int/hfamdb/
24. Freid V., Prager K., MacKay A., and Xia H. Chartbook on trends in the health of Americans. Health, United States, 2003 (2003), National Center for Health Statistics, Hyattsville
25. Lin K.C., Tsai S.T., Kuo S.C., Tsay S.L., and Chou P. Interrelationship between insulin resistance and menopause on the metabolic syndrome and its individual component among nondiabetic women in the Kinmen study. Am J Med Sci 333 (2007) 208-214
26. Ekelund U., Franks P.W., Sharp S., Brage S., and Wareham N.J. Increase in physical activity energy expenditure is associated with reduced metabolic risk independent of change in fatness and fitness. Diabetes Care 30 (2007) 2101-2116
27. Bertrais S., Beyeme-Ondoua J.P., Czernichow S., et al. Sedentary behaviours, physical activity, and metabolic syndrome in middle-aged French subjects. Obes Res 13 (2005) 936-944
28. Park Y.W., Zhu S., Palaniappan L., et al. The metabolic syndrome: prevalence and associated risk factor findings in the US population from the Third National Health and Nutrition Examination Survey, 1988-1994. Arch Intern Med 163 (2003) 427-436
29. Pannier B., Thomas F., Eschwège E., et al. Cardiovascular risk markers associated with the metabolic syndrome in a large French population: the SYMFONIE study. Diabetes Metab 32 (2006) 467-474
30. Gregory C.O., Dai J., Ramírez-Cea M., and Stein A.D. Occupation is more important than rural or urban residence in explaining the prevalence of metabolic and cardiovascular disease risk in Guatemalan adults. J Nutr 137 (2007) 1314-1319
31. Fröhlich M., Imhof A., Berg G., et al. Association between C-reactive protein and features of the metabolic syndrome. A population-based study. Diabetes Care 23 (2000) 1835-1839
32. Juhan-Vague I., Thompson S.G., and Jespersen J. Involvement of the hemostatic system in the insulin resistance syndrome: a study of 1,500 patients with angina pectoris. Arterioscler Thromb 13 (1993) 1865-1873
33. Malik S., Wong N.D., Franklin S., et al. Cardiovascular disease in U.S. patients with metabolic syndrome, diabetes, and elevated C-reactive protein. Diabetes Care 28 (2005) 690-693